Improvement of the functionality of pancreatic Langerhans islets via reduction of bacterial contamination and apoptosis using phenolic compounds

Publish Year: 1397
نوع سند: مقاله ژورنالی
زبان: English
View: 194

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-21-9_008

تاریخ نمایه سازی: 27 مهر 1400

Abstract:

Objective(s): During type-۱ diabetes treating by pancreatic islet transplantation, increasing oxidative stress and microbial contaminations are the main reasons of transplantation failure. In this study, we evaluated anti-apoptotic, antioxidant and antimicrobial potentials of phenolic compounds called ellagic acid (EA) and silybin on rat pancreatic islets. Materials and Methods: By doing MTT assay, effective concentrations of EA and silybin were determined as ۱۵۰۰ and ۲۱۰۰ μM, respectively. Then, ELISA methods, flow cytometry and MIC were done to investigate antioxidant, anti-apoptotic and antibacterial effects of those compounds, respectively.Results: Results of FITC Annexin-V and PI staining via flow cytometry, and also caspase-۳ and -۹ activities performed that EA has anti-apoptotic effects on pancreatic cells. Both compounds significantly diminished reactive oxygen species, and enhanced antioxidant power and insulin secretion. Furthermore, the minimum inhibitory concentration test indicated that these two have antibacterial effects on both Gram-positive and Gram-negative bacteria which usually contaminate the pancreatic islets.Conclusion: These findings support that use of EA and silybin can improve the function of islets which are used in transplantation, along with decreasing islets bacterial contamination.

Keywords:

Antibacterial , Apoptosis , Ellagic acid , Islets of Langerhans , Islet transplantation Oxidative stress , Silybin

Authors

Mahban Rahimifard

Toxicology and Diseases Group, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran

Shermineh Moeini-Nodeh

Toxicology and Diseases Group, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran

Kamal Niaz

Toxicology and Diseases Group, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran

Maryam Baeeri

Toxicology and Diseases Group, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran

Hossein Jamalifar

Toxicology and Diseases Group, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran

Mohammad Abdollahi

Toxicology and Diseases Group, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Yin N, Chen T, Yu Y, Han Y, Yan F, ...
  • Rahimifard M, Navaei-Nigjeh M, Mahroui N, Mirzaei S, Siahpoosh Z, ...
  • Santos‐Buelga C, Scalbert A. Proanthocyanidins and tannin‐like compounds–nature, occurrence, dietary ...
  • Gu L, Kelm MA, Hammerstone JF, Beecher G, Holden J, ...
  • Clifford MN, Scalbert A. Ellagitannins–nature, occurrence and dietary burden. J ...
  • Goodwin EC, Atwood WJ, Dimaio D. High-throughput cell-based screen for ...
  • Nohynek LJ, Alakomi HL, Kähkönen MP, Heinonen M, Helander IM, ...
  • Beserra AM, Calegari PI, Souza MC, Dos Santos RA, Lima ...
  • Iakovleva L, Ivakhnenko A, Buniatian N. The protective action of ...
  • Kaur R, Sharma U, Singh B, Arora S. Antimutagenic and ...
  • Iqbal J, Zaib S, Farooq U, Khan A, Bibi I, ...
  • Dell’agli M, Parapini S, Basilico N, Verotta L, Taramelli D, ...
  • Yoon CH, Chung SJ, Lee SW, Park YB, Lee SK, ...
  • Forester SC, Choy YY, Waterhouse AL Oteiza PI. The anthocyanin ...
  • Baeeri M, Mohammadi-Nejad S, Rahimifard M, Navaei-Nigjeh M, Moeini-Nodeh S, ...
  • Vattem D, Shetty K. Biological functionality of ellagic acid: a ...
  • Friling RS, Bensimon A, Tichauer Y, Daniel V. Xenobiotic-inducible expression ...
  • Wiseman H, Halliwell B. Damage to DNA by reactive oxygen ...
  • Bisen PS, Bundela SS, harma A. Ellagic Acid? chemopreventive role ...
  • Weisburg JH, Schuck AG, Reiss SE, Wolf BJ, Fertel SR, ...
  • Li TM, Chen GW, Su CC, Lin JG, Yeh CC, ...
  • Zhang HM, Zhao Li, Xu H, Chen WW, Tao L. ...
  • Saeidnia S, Abdollahi M. Antioxidants: Friends or foe in prevention ...
  • Loguercio C, Festi D. Silybin and the liver: from basic ...
  • Gazak R, Walterova D, Kren V. Silybin and silymarin-new and ...
  • Dashti-Khavidaki S, Shahbazi F, Khalili H, Lessan-Pezeshki M. Potential renoprotective ...
  • Dehmlow C, Erhard J, De Groot H. Inhibition of Kupffer ...
  • Yoo HG, Jungm SN, Hwang YS, Park JS, Kim MH, ...
  • Katiyar SK, Roy AM, Baliga MS. Silymarin induces apoptosis primarily ...
  • Fallahzadeh MK, Dormanesh B, Sagheb MM, Roozbeh J, Vessal G, ...
  • Vessal G, Akmali M, Najafi P, Moein MR, Sagheb MM. ...
  • Ylipaasto P, Klingel K, Lindberg AM, Otonkoski T, Kandolf R, ...
  • Bucher P, Oberholzer J, Bosco D, Mathe Z, Toso C, ...
  • Shah SMM, Khan FA, Shah SMH, Chishti KA, et al. ...
  • Moeini-Nodeh S, Rahimifard M, Baeeri M, Abdollahi M. Functional improvement ...
  • Rahimifard M, Navaii-Nigjeh M, Nilli-Ahmadabadi A, Pourkhalili N, Baeeri M, Mohammadirad A , ...
  • Shoae-Hagh P, Rahimifard M, Navaei-Nigjeh M, Baeeri M, Gholami M, ...
  • Maqbool F, Bahadar H, Niaz K, Baeeri M, Rahimifard M, ...
  • Bahadar H, Maqbool F, Mostafalou S, Baeeri M, Rahimifard M, ...
  • Jowzi N, Rahimifard M, Navaei-Nigjeh M, Baeeri M, Darvishi B, ...
  • Yousefbeyk F, Gohari AR, Hashemighahderijani Z, Ostad SN, Sourmaghi MHS, ...
  • Benavente-Garcia O, Castillo J. Update on uses and properties of ...
  • Jadhav R, Puchchakayala G. Hypoglycemic and antidiabetic activity of flavonoids: ...
  • Rahimifard M, Maqbool F, Moeini-Nodeh S, Niaz K, Abdollahi M, ...
  • El-Shitany NA, El-Bastawissy EA, El-Desoky K. Ellagic acid protects against ...
  • Ghasemi-Niri SF, Maqbool F, Baeeri M, Gholami M , Abdollahi ...
  • Tyagi AK, Agarwal C, Singh RP, Shroyer KR, Glode LM, ...
  • Slavov E, Georgiev IP, Dzhelebov P, Kanelov I, Andonova M, ...
  • Walker FR, Owens J, Ali S, Hodgson DM. Individual differences ...
  • Alves MJ, Ferreira IC, Froufe HJ, Abreu RMV, Martins A ...
  • Nikolić DM, Đorđević PB, Dimitrijević-Srećković V, Džingalašević M, Belij S, ...
  • Mandel TE. Fetal islet transplantation in diabetic mice: a model ...
  • Berger MG, Majumder K, Hodges JS, Bellin MD, Schwarzenberg SJ, ...
  • Sugiura T, Mizuno T, Okamura Y, Ito T, Yamamoto Y, ...
  • Baumann CA, Saltiel AR. Spatial compartmentalization of signal transduction in ...
  • Fernández-Real JM, López-Bermejo A, Vendrell J, Ferri MJ, Recasens M, ...
  • Mohseni Salehi Monfared SS, Larijani B, Abdollahi M. Islet transplantation ...
  • نمایش کامل مراجع